---
title: "Adaptive Immunity"
order: 2
category: "Immunology"
---

# Adaptive Immunity

## Overview

Adaptive immunity provides specific, long-lasting protection against pathogens through immunological memory. It consists of cellular and humoral components that recognize specific antigens, mount targeted responses, and remember encounters for faster future responses. This system takes days to weeks to develop but provides superior specificity and memory compared to innate immunity.

### Key Characteristics
- **Specificity**: Recognizes unique molecular features (epitopes)
- **Memory**: Faster and stronger secondary responses
- **Diversity**: >10^11 different antigen receptors possible
- **Self-tolerance**: Distinguishes self from non-self antigens

## Antigen Recognition

### Antigens and Epitopes
- **Antigen**: Any molecule that can be recognized by adaptive immune system
- **Epitope**: Specific region of antigen recognized by receptor
- **Hapten**: Small molecule that becomes antigenic when bound to carrier
- **Immunogen**: Antigen capable of inducing immune response

### Major Histocompatibility Complex (MHC)
- **MHC Class I**: Present on all nucleated cells, present intracellular peptides
- **MHC Class II**: Present on antigen-presenting cells, present extracellular peptides
- **Function**: Self-recognition and antigen presentation
- **Polymorphism**: High variability in population

### Antigen Processing and Presentation
#### MHC Class I Pathway
1. **Proteasomal degradation**: Intracellular proteins processed
2. **TAP transport**: Peptides transported to ER
3. **MHC loading**: Peptides loaded onto MHC I molecules
4. **Surface expression**: MHC I-peptide complexes displayed

#### MHC Class II Pathway
1. **Endocytosis**: Extracellular antigens internalized
2. **Lysosomal processing**: Proteins degraded in acidic compartments
3. **CLIP displacement**: Invariant chain removed, peptides loaded
4. **Surface expression**: MHC II-peptide complexes displayed

## T Cell Biology

### T Cell Development
- **Thymic education**: Positive and negative selection
- **Positive selection**: Recognition of self-MHC
- **Negative selection**: Elimination of self-reactive cells
- **Central tolerance**: Prevention of autoimmunity

### T Cell Receptor (TCR)
- **Structure**: Heterodimer (αβ or γδ chains)
- **Diversity**: V(D)J recombination generates variety
- **CD3 complex**: Signal transduction machinery
- **Coreceptors**: CD4 (MHC II) or CD8 (MHC I)

### T Cell Subsets

#### CD4+ Helper T Cells
- **Th1 cells**: Cell-mediated immunity, intracellular pathogens
  - Cytokines: IFN-γ, IL-2, TNF-α
  - Functions: Macrophage activation, CTL help

- **Th2 cells**: Humoral immunity, parasites, allergies
  - Cytokines: IL-4, IL-5, IL-13
  - Functions: B cell help, eosinophil activation

- **Th17 cells**: Inflammation, extracellular bacteria/fungi
  - Cytokines: IL-17A, IL-17F, IL-22
  - Functions: Neutrophil recruitment, barrier function

- **Tfh cells**: Follicular helper T cells
  - Location: Germinal centers
  - Function: B cell help, affinity maturation

- **Treg cells**: Regulatory T cells
  - Markers: CD25+, FoxP3+
  - Function: Immune suppression, tolerance

#### CD8+ Cytotoxic T Cells
- **Recognition**: MHC I-peptide complexes
- **Cytotoxicity**: Perforin, granzymes, Fas ligand
- **Targets**: Virus-infected, tumor, transplanted cells
- **Memory**: Long-lived protection

### T Cell Activation
1. **Signal 1**: TCR-MHC-peptide interaction
2. **Signal 2**: Costimulatory molecules (CD28-B7)
3. **Signal 3**: Cytokine environment determines differentiation
4. **Clonal expansion**: Proliferation of activated cells

## B Cell Biology

### B Cell Development
- **Bone marrow**: Primary lymphoid organ
- **Stages**: Pro-B, pre-B, immature B, mature B
- **Selection**: Removal of self-reactive B cells
- **BCR expression**: Surface immunoglobulin

### B Cell Receptor (BCR)
- **Structure**: Surface immunoglobulin + Igα/Igβ
- **Diversity**: V(D)J recombination, somatic hypermutation
- **Isotypes**: IgM, IgD (naive), IgG, IgA, IgE (switched)
- **Affinity maturation**: Somatic hypermutation in germinal centers

### B Cell Activation
#### T-Independent Activation
- **Type 1**: Polyclonal activators (LPS)
- **Type 2**: Repetitive antigens (polysaccharides)
- **Response**: Rapid but short-lived, no memory

#### T-Dependent Activation
1. **Antigen recognition**: BCR binds antigen
2. **Antigen presentation**: Processed antigen on MHC II
3. **T cell help**: CD40L-CD40, cytokines
4. **Germinal center formation**: Somatic hypermutation, selection

### Antibody Structure and Function

#### Immunoglobulin Structure
- **Heavy chains**: Define antibody class
- **Light chains**: Kappa or lambda
- **Variable regions**: Antigen binding
- **Constant regions**: Effector functions

#### Antibody Classes
- **IgM**: First response, complement activation, pentamer
- **IgG**: Most abundant, opsonization, complement, placental transfer
- **IgA**: Mucosal immunity, secretory component
- **IgE**: Allergic reactions, parasites, mast cell degranulation
- **IgD**: B cell receptor, unclear effector function

#### Antibody Functions
- **Neutralization**: Blocks pathogen attachment/entry
- **Opsonization**: Enhances phagocytosis via Fc receptors
- **Complement activation**: Classical pathway initiation
- **ADCC**: Antibody-dependent cellular cytotoxicity

## Memory and Secondary Responses

### Memory T Cells
- **Central memory**: TCM, lymphoid organs, high proliferative capacity
- **Effector memory**: TEM, peripheral tissues, immediate function
- **Tissue resident memory**: TRM, remain in tissues long-term
- **Longevity**: Maintain themselves for decades

### Memory B Cells
- **Characteristics**: Class-switched, high-affinity BCR
- **Location**: Secondary lymphoid organs, circulation
- **Reactivation**: Rapid differentiation to plasma cells
- **Somatic hypermutation**: Enhanced affinity

### Secondary Immune Response
- **Kinetics**: Faster onset, higher magnitude
- **Affinity**: Higher affinity antibodies
- **Isotype**: Predominantly IgG rather than IgM
- **Duration**: More sustained response

## Immunological Tolerance

### Central Tolerance
- **Location**: Primary lymphoid organs (thymus, bone marrow)
- **Mechanism**: Deletion of self-reactive lymphocytes
- **T cells**: Negative selection in thymus
- **B cells**: Deletion or receptor editing

### Peripheral Tolerance
- **Anergy**: Functional inactivation
- **Deletion**: Activation-induced cell death
- **Suppression**: Regulatory T cell function
- **Ignorance**: Physical separation of antigens

### Regulatory Mechanisms
- **Tregs**: FoxP3+ regulatory T cells
- **IL-10**: Anti-inflammatory cytokine
- **TGF-β**: Immune suppression and tolerance
- **CTLA-4**: Inhibitory receptor on T cells

## Hypersensitivity Reactions

### Type I (Immediate)
- **Mechanism**: IgE-mediated mast cell degranulation
- **Timing**: Minutes
- **Examples**: Anaphylaxis, asthma, food allergies
- **Mediators**: Histamine, leukotrienes, prostaglandins

### Type II (Cytotoxic)
- **Mechanism**: IgG/IgM against cell surface antigens
- **Timing**: Hours
- **Examples**: Hemolytic anemia, thrombocytopenia
- **Effectors**: Complement, ADCC, phagocytosis

### Type III (Immune Complex)
- **Mechanism**: Immune complex deposition
- **Timing**: Hours to days
- **Examples**: Serum sickness, lupus nephritis
- **Pathology**: Complement activation, inflammation

### Type IV (Delayed)
- **Mechanism**: T cell-mediated
- **Timing**: 48-72 hours
- **Examples**: Contact dermatitis, tuberculin test
- **Effectors**: Th1 cells, macrophages, CTLs

## Clinical Applications

### Vaccination
- **Active immunization**: Antigen administration induces immunity
- **Passive immunization**: Transfer of preformed antibodies
- **Vaccine types**: Live attenuated, inactivated, subunit, mRNA
- **Adjuvants**: Enhance immune responses

### Immunotherapy
- **Monoclonal antibodies**: Targeted therapy
- **Checkpoint inhibitors**: Anti-PD-1, anti-CTLA-4
- **CAR-T cells**: Genetically modified T cells
- **Immune modulators**: Cytokines, growth factors

### Transplantation
- **HLA matching**: Minimize rejection risk
- **Immunosuppression**: Prevent rejection
- **Tolerance induction**: Long-term acceptance
- **Graft-versus-host disease**: Donor T cells attack recipient

### Autoimmune Diseases
- **Pathogenesis**: Loss of self-tolerance
- **Examples**: Type 1 diabetes, multiple sclerosis, rheumatoid arthritis
- **Treatment**: Immunosuppression, targeted therapy
- **Biomarkers**: Autoantibodies, immune cell subsets

## Immunodeficiencies

### Primary Immunodeficiencies
- **B cell defects**: Agammaglobulinemia, CVID
- **T cell defects**: SCID, DiGeorge syndrome
- **Combined defects**: Ataxia telangiectasia
- **Phagocyte defects**: Chronic granulomatous disease

### Secondary Immunodeficiencies
- **HIV/AIDS**: CD4+ T cell depletion
- **Malnutrition**: Multiple immune defects
- **Immunosuppressive drugs**: Iatrogenic immunosuppression
- **Cancer**: Immune system compromise

## Laboratory Assessment

### Cellular Immunity
- **Flow cytometry**: T cell subsets, activation markers
- **Proliferation assays**: T cell function
- **Cytokine production**: Th1/Th2/Th17 responses
- **Delayed hypersensitivity**: Skin testing

### Humoral Immunity
- **Immunoglobulin levels**: IgG, IgA, IgM, IgE
- **Specific antibodies**: Vaccine responses, autoantibodies
- **Functional assays**: Opsonization, complement activation
- **B cell subsets**: Memory, plasma cells

### Advanced Techniques
- **HLA typing**: Transplantation compatibility
- **TCR/BCR sequencing**: Immune repertoire analysis
- **Multiplex cytokine assays**: Comprehensive immune profiling
- **Single-cell analysis**: Individual cell characterization

## Key Points

- Adaptive immunity provides specific, long-lasting protection through T and B cells
- Antigen processing and presentation via MHC molecules is crucial for T cell activation
- T helper cells orchestrate immune responses through cytokine production
- B cells produce antibodies that neutralize pathogens and enhance clearance
- Memory cells provide rapid secondary responses upon re-exposure
- Immunological tolerance prevents autoimmune diseases
- Hypersensitivity reactions represent inappropriate immune responses
- Vaccination exploits adaptive immunity for disease prevention
- Immunodeficiencies compromise adaptive immune function
- Understanding adaptive immunity is essential for immunotherapy development

## References

1. Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 9th ed. Elsevier; 2017.
2. Murphy K, Weaver C. Janeway's Immunobiology. 9th ed. Garland Science; 2016.
3. Owen JA, Punt J, Stranford SA. Kuby Immunology. 8th ed. W.H. Freeman; 2019.